cdc travel vaccines haiti

Security Alert May 17, 2024

Worldwide caution, update may 10, 2024, information for u.s. citizens in the middle east.

• Travel Advisories |
• Contact Us |
• MyTravelGov |

Find U.S. Embassies & Consulates

Travel.state.gov, congressional liaison, special issuance agency, u.s. passports, international travel, intercountry adoption, international parental child abduction, records and authentications, popular links, travel advisories, mytravelgov, stay connected, legal resources, legal information, info for u.s. law enforcement, replace or certify documents.

Share this page:

Haiti Travel Advisory

Travel advisory july 27, 2023, haiti - level 4: do not travel.

Last Update: Updated to reflect the Ordered Departure of non-emergency U.S. government personnel and eligible family members for Embassy Port-au-Prince.

Do not travel to Haiti due to kidnapping, crime, civil unrest, and poor health care infrastructure. On July 27, 2023, the Department of State ordered the departure of family members of U.S. government employees and non-emergency U.S. government employees. U.S. citizens in Haiti should depart Haiti as soon as possible by commercial or other privately available transportation options, in light of the current security situation and infrastructure challenges. U.S. citizens wishing to depart Port-au-Prince should monitor local news and only do so when considered safe.

Country Summary : Kidnapping is widespread, and victims regularly include U.S. citizens. Kidnappers may use sophisticated planning or take advantage of unplanned opportunities, and even convoys have been attacked. Kidnapping cases often involve ransom negotiations and U.S. citizen victims have been physically harmed during kidnappings. Victim’s families have paid thousands of dollars to rescue their family members.

Violent crime, often involving the use of firearms, such as  armed robbery, carjackings, and kidnappings for ransom that include U.S. citizens are common. Mob killings against presumed criminals have been on the rise since late April. Travelers are sometimes followed and violently attacked and robbed shortly after leaving the Port-au-Prince international airport. Robbers and carjackers also attack private vehicles stuck in heavy traffic congestion and often target lone drivers, particularly women. As a result, the U.S. Embassy requires its personnel to use official transportation to and from the airport.

Protests, demonstrations, tire burning, and roadblocks are frequent, unpredictable, and can turn violent. The U.S. government is extremely limited in its ability to provide emergency services to U.S. citizens in Haiti – assistance on site is available only from local authorities (Haitian National Police and ambulance services). Local police generally lack the resources to respond effectively to serious criminal incidents. Shortages of gasoline, electricity, medicine, and medical supplies continue throughout much of Haiti. Public and private medical clinics and hospitals often lack qualified medical staff and even basic medical equipment and resources.

U.S. government personnel are limited only to the confined area around the Embassy and are prohibited from walking in Port-au-Prince. U.S. government personnel in Haiti are prohibited from:

• Using any kind of public transportation or taxis
• Visiting banks and using ATMs
• Driving at night
• Traveling anywhere between 1:00 a.m. and 5:00 a.m.
• Traveling without prior approval and special security measures in place.

Read the  country information page  for additional information on travel to Haiti.

The Haitian Ministry of Health and Population (MSPP) has confirmed an outbreak of cholera in the country.  

If you decide to travel to Haiti:

• Avoid demonstrations and crowds. Do not attempt to drive through roadblocks.
• Arrange airport transfers and hotels in advance, or have your host meet you upon arrival.
• Do not provide personal information to unauthorized individuals (e.g. people without official uniforms or credentials) located in the immigration, customs, or other areas inside or near any airports.
• If you are being followed as you leave the airport, drive to the nearest police station immediately.
• Travel by vehicle to minimize walking in public.
• Travel in groups of at least two people.
• Always keep vehicle doors locked and windows closed when driving.
• Exercise caution and alertness, especially when driving through markets and other traffic congested areas.
• Do not physically resist any robbery attempt.
• Purchase travel insurance and medical evacuation insurance ahead of time.
• Review information on  Travel to High-Risk Areas .
• Enroll in the  Smart Traveler Enrollment Program (STEP)  to receive Alerts and make it easier to locate you in an emergency.
• Follow the Department of State on  Facebook  and  Twitter .
• Review the  Country Security Report  on Haiti.
• Prepare a contingency plan for emergency situations. Review the  Traveler’s Checklist .

Travel Advisory Levels

Assistance for u.s. citizens, search for travel advisories, external link.

You are about to leave travel.state.gov for an external website that is not maintained by the U.S. Department of State.

Links to external websites are provided as a convenience and should not be construed as an endorsement by the U.S. Department of State of the views or products contained therein. If you wish to remain on travel.state.gov, click the "cancel" message.

You are about to visit:

You are using an outdated browser. Upgrade your browser today or install Google Chrome Frame to better experience this site.

• Section 2 - Vaccination & Immunoprophylaxis— General Principles
• Section 2 - Yellow Fever Vaccine & Malaria Prevention Information, by Country

Interactions Between Travel Vaccines & Drugs

Cdc yellow book 2024.

Author(s): Ilan Youngster, Elizabeth Barnett

Vaccine–Vaccine Interactions

Travel vaccines & drugs, antimalarial drugs, drugs used for travel to high elevations, hiv medications, herbal & nutritional supplements.

During pretravel consultations, travel health providers must consider potential interactions between vaccines and medications, including those already taken by the traveler. A study by S. Steinlauf et al. identified potential drug–drug interactions with travel-related medications in 45% of travelers taking medications for chronic conditions; 3.5% of these interactions were potentially serious.

Most common vaccines can be given safely and effectively at the same visit, at separate injection sites, without impairing antibody response or increasing rates of adverse reactions. However, certain vaccines, including pneumococcal and meningococcal vaccines and live virus vaccines, require appropriate spacing; further information about vaccine–vaccine interactions is found in Sec. 2, Ch. 3, Vaccination & Immunoprophylaxis—General Principles .

Live Attenuated Oral Typhoid & Cholera Vaccines

Live attenuated vaccines generally should be avoided in immunocompromised travelers, including those taking antimetabolites, calcineurin inhibitors, cytotoxic agents, immunomodulators, and high-dose steroids (see Table 3-04 ).

Chloroquine and atovaquone-proguanil at doses used for malaria chemoprophylaxis can be given concurrently with oral typhoid vaccine. Data from an older formulation of the CVD 103-HgR oral cholera vaccine suggest that the immune response to the vaccine might be diminished when given concomitantly with chloroquine. Administer live attenuated oral cholera vaccine ≥10 days before beginning antimalarial prophylaxis with chloroquine. A study in children using oral cholera vaccine suggested no decrease in immunogenicity when given with atovaquone-proguanil.

Antimicrobial Agents

Antimicrobial agents can be active against the vaccine strains in the oral typhoid and cholera vaccines and might prevent adequate immune response to these vaccines. Therefore, delay vaccination with oral typhoid vaccine by >72 hours and delay oral cholera vaccine by >14 days after administration of antimicrobial agents. Parenteral typhoid vaccine is an alternative to the oral typhoid vaccine for travelers who have recently received antibiotics.

Rabies Vaccine

Concomitant use of chloroquine can reduce the antibody response to intradermal rabies vaccine administered as a preexposure vaccination. Use the intramuscular route for people taking chloroquine concurrently. Intradermal administration of rabies vaccine is not currently approved for use in the United States (see Sec. 5, Part 2, Ch. 19, . . . perspectives: Rabies Immunization ).

Any time a new medication is prescribed, including antimalarial drugs, check for known or possible drug interactions (see Table 2-05 ) and inform the traveler of potential risks. Online clinical decision support tools (e.g., Micromedex) provide searchable databases of drug interactions.

Atovaquone-Proguanil

Antibiotics.

Rifabutin, rifampin, and tetracycline might reduce plasma concentrations of atovaquone and should not be used concurrently with atovaquone-proguanil.

• Anticoagulants

Patients on warfarin might need to reduce their anticoagulant dose or monitor their prothrombin time more closely while taking atovaquone-proguanil, although coadministration of these drugs is not contraindicated. The use of novel oral anticoagulants, including dabigatran, rivaroxaban, and apixaban, is not expected to cause significant interactions, and their use has been suggested as an alternative for patients in need of anticoagulation.

Antiemetics

Metoclopramide can reduce bioavailability of atovaquone; unless no other antiemetics are available, this antiemetic should not be used to treat vomiting associated with the use of atovaquone at treatment doses.

Antihistamines

Travelers taking atovaquone-proguanil for malaria prophylaxis should avoid using cimetidine (an H2 receptor antagonist) because this medication interferes with proguanil metabolism.

Atovaquone-proguanil might interact with the antiretroviral protease inhibitors atazanavir, darunavir, indinavir, lopinavir, and ritonavir, or the nonnucleoside reverse transcriptase inhibitors (NNRTIs) efavirenz, etravirine, and nevirapine, resulting in decreased levels of atovaquone-proguanil. For travelers taking any of these medications, consider alternative malaria chemoprophylaxis .

Selective Serotonin Reuptake Inhibitors

Fluvoxamine interferes with the metabolism of proguanil; consider an alternative antimalarial prophylaxis to atovaquone-proguanil for travelers taking this selective serotonin reuptake inhibitor (SSRI).

Chloroquine

Antacids & Antidiarrheals

Chloroquine absorption might be reduced by antacids or kaolin; travelers should wait ≥4 hours between doses of these medications.

Chloroquine inhibits bioavailability of ampicillin, and travelers should wait ≥2 hours between doses of these medications. Chloroquine should not be coadministered with either clarithromycin or erythromycin; azithromycin is a suggested alternative . Chloroquine also reportedly decreases the bioavailability of ciprofloxacin.

Concomitant use of cimetidine and chloroquine should be avoided because cimetidine can inhibit the metabolism of chloroquine and increase drug levels.

CYP2D6 Enzyme Substrates

Chloroquine is a CYP2D6 enzyme inhibitor. Monitor patients taking chloroquine concomitantly with other substrates of this enzyme (e.g., flecainide, fluoxetine, metoprolol, paroxetine, propranolol) for side effects.

CYP3A4 Enzyme Inhibitors

CYP3A4 inhibitors (e.g., erythromycin, ketoconazole, ritonavir) can increase chloroquine levels; concomitant use should be avoided.

Chloroquine can increase digoxin levels; additional monitoring is warranted.

Immunosuppressants

Chloroquine decreases the bioavailability of methotrexate. Chloroquine also can cause increased levels of calcineurin inhibitors; use caution when prescribing chloroquine to travelers taking these agents.

QT-Prolonging Agents

Avoid prescribing chloroquine to anyone taking other QT-prolonging agents (e.g., amiodarone, lumefantrine, sotalol); when taken in combination, chloroquine might increase the risk for prolonged QTc interval. In addition, the antiretroviral rilpivirine has also been shown to prolong QTc, and clinicians should avoid coadministration with chloroquine.

Doxycycline

Antacids, Bismuth Subsalicylate, Iron

Absorption of tetracyclines might be impaired by aluminum-, calcium-, or magnesium-containing antacids, bismuth subsalicylate, and preparations containing iron; advise patients not to take these preparations within 3 hours of taking doxycycline.

Doxycycline can interfere with the bactericidal activity of penicillin; thus, in general, clinicians should not prescribe these drugs together. Coadministration of doxycycline with rifabutin or rifampin can lower doxycycline levels; monitor doxycycline efficacy closely or consider alternative therapy.

Patients on warfarin might need to reduce their anticoagulant dose while taking doxycycline because of its ability to depress plasma prothrombin activity.

Anticonvulsants

Barbiturates, carbamazepine, and phenytoin can decrease the half-life of doxycycline.

Antiretrovirals

Doxycycline has no known interaction with antiretroviral agents.

Concurrent use of doxycycline and calcineurin inhibitors or mTOR inhibitors (sirolimus) can cause increased levels of these immunosuppressant drugs.

Mefloquine can interact with several categories of drugs, including anticonvulsants, other antimalarial drugs, and drugs that alter cardiac conduction.

Mefloquine can lower plasma levels of several anticonvulsant medications, including carbamazepine, phenobarbital, phenytoin, and valproic acid; avoid concurrent use of mefloquine with these agents.

Mefloquine is associated with increased toxicities of the antimalarial drug lumefantrine, which is available in the United States in fixed combination to treat people with uncomplicated Plasmodium falciparum malaria. The combination of mefloquine and lumefantrine can cause potentially fatal QTc interval prolongation. Lumefantrine should therefore be avoided or used with caution in patients taking mefloquine prophylaxis.

CYP3A4 Enzyme Inducers

CYP3A4 inducers include medications used to treat HIV or HIV-associated infections (e.g., efavirenz, etravirine, nevirapine, rifabutin) and tuberculosis (rifampin). St. John’s wort and glucocorticoids are also CYP3A4 inducers. All these drugs (rifabutin and rifampin, in particular) can decrease plasma concentrations of mefloquine, thereby reducing its efficacy as an antimalarial drug.

Potent CYP3A4 inhibitors (e.g., antiretroviral protease inhibitors, atazanavir, cobicistat [available in combination with elvitegravir], darunavir, lopinavir, ritonavir, saquinavir); azole antifungals (itraconazole, ketoconazole, posaconazole, voriconazole); macrolide antibiotics (azithromycin, clarithromycin, erythromycin); and SSRIs (fluoxetine, fluvoxamine, sertraline), can increase levels of mefloquine and thus increase the risk for QT prolongation.

Although no conclusive data are available regarding coadministration of mefloquine and other drugs that can affect cardiac conduction, avoid mefloquine use, or use it with caution, in patients taking antiarrhythmic or β-blocking agents, antihistamines (H1 receptor antagonists), calcium channel receptor antagonists, phenothiazines, SSRIs, or tricyclic antidepressants.

Concomitant use of mefloquine can cause increased levels of calcineurin inhibitors and mTOR inhibitors (cyclosporine A, sirolimus, tacrolimus).

Anti-Hepatitis C Virus Protease Inhibitors

Avoid concurrent use of mefloquine and direct-acting protease inhibitors (boceprevir and telaprevir) used to treat hepatitis C. Newer direct-acting protease inhibitors (grazoprevir, paritaprevir, simeprevir) are believed to be associated with fewer drug–drug interactions, but safety data are lacking; consider alternatives to mefloquine pending additional data.

Psychiatric Medications

Avoid prescribing mefloquine to travelers with a history of mood disorders or psychiatric disease; this information is included in the US Food and Drug Administration boxed warning for mefloquine.

Table 2-05 Drugs & drug classes that can interact with selected antimalarials

ANTIMALARIALS

DRUGS & DRUG CLASSES THAT CAN INTERACT

Atovaquone- proguanil

• Fluvoxamine
• Metoclopromide
• Tetracycline
• Calcineurin inhibitors
• Ciprofloxacin
• CYP2D6 enzyme substrates 1
• CYP3A4 enzyme inhibitors 2
• Methotrexate
• QT- prolonging agents 3
• Bismuth subsalicylate
• Barbiturates
• Carbamazepine
• Iron- containing preparations
• mTOR inhibitors
• Antiarrhythmic agents
• Beta blockers
• Calcium channel receptor antagonists
• CYP3A4 enzyme inducers 4
• H1 receptor antagonists
• Lumefantrine
• Phenothiazines
• Protease inhibitors
• Tricyclic antidepressants

1 Examples include flecainide, fluoxetine, metoprolol, paroxetine, and propranolol.

2 Examples include antiretroviral protease inhibitors (e.g., atazanavir, darunavir, lopinavir, ritonavir, saquinavir); azole antifungals (e.g., itraconazole, ketoconazole, posaconazole, voriconazole); macrolide antibiotics (e.g., azithromycin, clarithromycin, erythromycin); selective serotonin reuptake inhibitors (SSRIs; e.g., fluoxetine, fluvoxamine, sertraline); and cobicistat.

3 Examples include amiodarone, lumefantrine, and sotalol.

4 Examples include efavirenz, etravirine, nevirapine, rifabutin, rifampin, and glucocorticoids.

Drugs Used to Treat Travelers’ Diarrhea

Antimicrobials commonly prescribed as treatment for travelers’ diarrhea have the potential for interacting with several different classes of drugs ( Table 2-06 ). As mentioned previously, online clinical decision support tools provide searchable databases that can help identify interactions with medications a person may already be taking.

Azithromycin

Increased anticoagulant effects have been noted when azithromycin is used with warfarin; monitor prothrombin time for people taking these drugs concomitantly.

Because additive QTc prolongation can occur when azithromycin is used with the antimalarial artemether, avoid concomitant therapy.

Drug interactions have been reported with the macrolide antibiotics, clarithromycin and erythromycin; antiretroviral protease inhibitors; and the NNRTIs, efavirenz and nevirapine. Concomitant use of azithromycin and these drugs can increase the risk of QTc prolongation, but a short treatment course is not contraindicated for those without an underlying cardiac abnormality. When azithromycin is used with the protease inhibitor nelfinavir, advise patients about possible drug interactions.

Concurrent use of macrolides with calcineurin inhibitors can cause increased levels of drugs belonging to this class of immunosuppressants.

Fluoroquinolones

Concurrent administration of ciprofloxacin and antacids that contain magnesium or aluminum hydroxide can reduce bioavailability of ciprofloxacin.

An increase in the international normalized ratio (INR) has been reported when levofloxacin and warfarin are used concurrently.

Asthma Medication

Ciprofloxacin decreases clearance of theophylline and caffeine; clinicians should monitor theophylline levels when ciprofloxacin is used concurrently.

Immunosuppresants

Fluoroquinolones can increase levels of calcineurin inhibitors, and doses should be adjusted for renal function.

Sildenafil should not be used by patients taking ciprofloxacin; concomitant use is associated with increased rates of adverse effects. Ciprofloxacin and other fluoroquinolones should not be used in patients taking tizanidine.

Rifamycin SV

No clinical drug interactions have been studied. Because of minimal systemic rifamycin concentrations observed after the recommended dose, clinically relevant drug interactions are not expected.

Rifaximin is not absorbed in appreciable amounts by intact bowel, and no clinically significant drug interactions have been reported to date with rifaximin except for minor changes in INR when used concurrently with warfarin.

Table 2-06 Drugs & drug classes that can interact with selected antibiotics

ANTIBIOTICS

• HIV medications
• Antacids containing magnesium or aluminum hydroxide
• Theophylline

No clinical drug interactions have been studied; none are expected

Before prescribing the carbonic anhydrase inhibitor, acetazolamide, to those planning high elevation travel, carefully review with them the complete list of medications they are already taking ( Table 2-07 ).

Acetazolamide

Acetaminophen & Diclofenac Sodium

Acetaminophen and diclofenac sodium form complex bonds with acetazolamide in the stomach’s acidic environment, impairing absorption. Neither agent should be taken within 30 minutes of acetazolamide. Patients taking acetazolamide also can experience decreased excretion of anticholinergics, dextroamphetamine, ephedrine, mecamylamine, mexiletine, and quinidine.

Acetazolamide should not be given to patients taking the anticonvulsant topiramate because concurrent use is associated with toxicity.

Barbiturates & Salicylates

Acetazolamide causes alkaline urine, which can increase the rate of excretion of barbiturates and salicylates and could cause salicylate toxicity, particularly in patients taking a high dose of aspirin.

• Corticosteroids

Hypokalemia caused by corticosteroids could occur when used concurrently with acetazolamide.

Diabetes Medications

Use caution when concurrently administering metformin and acetazolamide because of increased risk for lactic acidosis.

Monitor cyclosporine, sirolimus, and tacrolimus more closely when given with acetazolamide.

Dexamethasone

Using dexamethasone to treat altitude illness can be lifesaving. Dexamethasone interacts with several classes of drugs, however, including: anticholinesterases, anticoagulants, digitalis preparations, hypoglycemic agents, isoniazid, macrolide antibiotics, oral contraceptives, and phenytoin.

Table 2-07 Drugs & drug classes that can interact with selected altitude illness drugs

ALTITUDE ILLNESS DRUG

• Acetaminophen
• Anticholinergics
• Aspirin, high dose
• Dextroamphetamine
• Diclofenac sodium
• Mecamylamine
• Anticholinesterases
• Digitalis preparations
• Hypoglycemic agents
• Macrolide antibiotics
• Oral contraceptives

Patients with HIV require additional consideration in the pretravel consultation (see Sec. 3, Ch. 1, Immunocompromised Travelers ). A study from Europe showed that ≤29% of HIV-positive travelers disclose their disease and medication status when seeking pretravel advice. Antiretroviral medications have multiple drug interactions, especially through their activation or inhibition of the CYP3A4 and CYP2D6 enzymes.

Several instances of antimalarial prophylaxis and treatment failure in patients taking protease inhibitors and both nucleoside and NNRTIs have been reported. By contrast, entry and integrase inhibitors are not a common cause of drug–drug interactions with commonly administered travel-related medications. Several potential interactions are listed above, and 2 excellent resources for HIV medication interactions can be found at  HIV Drug Interactions and HIV.gov . HIV preexposure prophylaxis with emtricitabine/tenofovir is not a contraindication for any of the commonly used travel-related medications.

Up to 30% of travelers take herbal or nutritional supplements. Many travelers consider them to be of no clinical relevance and might not disclose their use unless specifically asked during the pretravel consultation. Clinicians should give special attention to supplements that activate or inhibit CYP2D6 or CYP3A4 enzymes (e.g., ginseng, grapefruit extract, hypericum, St. John’s wort). Advise patients against coadministration of herbal and nutritional supplements with medications that are substrates for CYP2D6 or 3A4 enzymes, including chloroquine, macrolides, and mefloquine.

The following authors contributed to the previous version of this chapter: Ilan Youngster, Elizabeth D. Barnett

Bibliography

Frenck RW Jr., Gurtman A, Rubino J, Smith W, van Cleeff M, Jayawardene D, et al. Randomized, controlled trial of a 13-valent pneumococcal conjugate vaccine administered concomitantly with an influenza vaccine in healthy adults. Clin Vaccine Immunol. 2012;19(8):1296–303.

Jabeen E, Qureshi R, Shah A. Interaction of antihypertensive acetazolamide with nonsteroidal anti-inflammatory drugs. J Photochem Photobiol B. 2013;125:155–63.

Kollaritsch H, Que JU, Kunz C, Wiedermann G, Herzog C, Cryz SJ Jr. Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccine. J Infect Dis. 1997;175(4):871–5.

Nascimento Silva JR, Camacho LA, Siqueira MM, Freire Mde S, Castro YP, Maia Mde L, et al. Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella. Vaccine. 2011;29(37):6327–34.

Nielsen US, Jensen-Fangel S, Pedersen G, Lohse N, Pedersen C, Kronborg G, et al. Travelling with HIV: a cross sectional analysis of Danish HIV-infected patients. Travel Med Infect Dis. 2014;12(1):72–8.

Ridtitid W, Wongnawa M, Mahatthanatrakul W, Raungsri N, Sunbhanich M. Ketoconazole increases plasma concentrations of antimalarial mefloquine in healthy human volunteers. J Clin Pharm Ther. 2005;30(3):285–90.

Sbaih N, Buss B, Goyal D, Rao SR, Benefield R, Walker AT, et al. Potentially serious drug interactions resulting from the pre-travel health encounter. Open Forum Infect Dis. 2018;5(11):ofy266.

Stienlauf S, Meltzer E, Kurnik D, Leshem E, Kopel E, Streltsin B, et al. Potential drug interactions in travelers with chronic illnesses: a large retrospective cohort study. Travel Med Infect Dis. 2014;12(5):499–504.

File Formats Help:

• Adobe PDF file
• Microsoft PowerPoint file
• Microsoft Word file
• Microsoft Excel file
• Audio/Video file
• Apple Quicktime file
• RealPlayer file
• Zip Archive file

Exit Notification / Disclaimer Policy

• The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
• Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
• You will be subject to the destination website's privacy policy when you follow the link.
• CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.

• High contrast
• Press Centre

Search UNICEF

Statement on the arrival of the first batch of covid-19 vaccines in haiti, statement by jean gough, unicef regional director for latin america and the caribbean.

PANAMA CITY, 14 July 2021 - "Until yesterday, Haiti was the only country in the Americas without a single dose of a COVID-19 vaccine. Today, 500,000 doses of vaccine donated by the U.S government through COVAX landed in Port-Au-Prince, the capital city of Haiti.

"In the first five months of this year, the number of COVID-19 cases and deaths has nearly doubled in Haiti. Amidst this recent upsurge, each of these 500,000 doses brings a ray of light to the Caribbean country, especially in times when increased urban violence threatens the well-being of children and families.

"Thanks to this donation, hundreds of thousands of Haitians will receive their shots against COVID-19. Yet, despite the collective efforts to kickstart the vaccination campaign soon, most of the Haitian population is at risk of remaining unvaccinated due to the limited availability of doses currently in the country.

"We hope this first donation of doses will be followed by others. More donations from well-supplied countries will be needed for Haiti and other countries in Latin America and the Caribbean to reach those most vulnerable to COVID-19 infection.

"Anywhere in the world, rolling out a largescale COVID-19 vaccination campaign is a daunting task. But in the current Haitian context, it is going to be an uphill battle for our teams in the coming weeks and months.

"When gangs are shooting at each other in the streets, transporting vaccines safely from one health center to the other every day is a victory. Without reliable electricity, keeping large number of vaccine doses always cool throughout the journey is a feat. 

"To speed up the upcoming COVID-19 vaccination campaign, UNICEF has been working around the clock to enhance transportation, increase mass communication and strengthen the cold chain across the country. In almost every single health center of Haiti, our teams have installed solar fridges to keep vaccines at the right temperature –over 900 in total. 

"In the context of Haiti where vaccine hesitancy is high, reaching communities with doses of vaccines doesn’t guarantee they want to get vaccinated. According to the preliminary results of a UNICEF-supported perception study conducted by the University of Haiti in June, only 22 per cent of all Haitians would accept to be vaccinated. 

"Together with the Haitian authorities, the Pan American Health Organization (PAHO) and other partners, UNICEF is committed to make extra efforts in response to the long-awaited need for vaccines in Haiti until the most vulnerable groups of the population are protected against COVID-19.

"As vaccines touched ground at the Port-au-Prince airport, our toughest job on the ground has yet to begin. Unless each of these 500,000 doses gets into the arms of Haitian people swiftly and safely, COVID-19 vaccines won’t help save Haitian lives and curb the spread of the pandemic in the Americas.

"Last June, urban violence among armed groups escalated in several areas of the capital city during a spike of COVID-19 cases. Over 15,000 women and children have now been forced to flee their home. Rising insecurity and clashes between gangs have seriously hindered humanitarian operations in the outskirts of Port-au-Prince."

Media contacts

Additional resources.

Additional resources for media 

About UNICEF

UNICEF works in some of the world’s toughest places, to reach the world’s most disadvantaged children. Across more than 190 countries and territories, we work for every child, everywhere, to build a better world for everyone.

Follow UNICEF on Twitter ,  Facebook , Instagram and YouTube

Related topics

More to explore.

At least 3 million children at risk as Hurricane Beryl hits the Caribbean

One child displaced every minute in Haiti as armed violence persists – UNICEF

Sudan is facing an unprecedented hunger catastrophe, say UN agency chiefs

UNICEF Executive Director Catherine Russell warns of a deepening crisis for children following a visit to Sudan

• Skip to main content
• Skip to "About this site"

Language selection

Search travel.gc.ca.

Help us to improve our website. Take our survey !

COVID-19: travel health notice for all travellers

Haiti travel advice

Latest updates: Risk level, Natural disasters and climate – added information on Hurricane Beryl

Last updated: July 2, 2024 16:42 ET

On this page

Safety and security, entry and exit requirements, laws and culture, natural disasters and climate, haiti - avoid all travel.

The security situation remains volatile in Haiti. You should consider leaving the country by commercial means if you can do so safely.

Back to top

Security situation in Haiti

The security situation remains extremely volatile in Haiti.

On March 3, 2024, the government of Haiti declared a state of emergency in Ouest Department, including in Port-au-Prince, in response to gang violence and the deteriorating security situation.

Demonstrations are prohibited in the Ouest Department. There are frequent clashes between gangs and security forces. Kidnappings, robberies, and violent crime are increasing.

While the state of emergency is in effect:

• follow the instructions of local authorities
• always cooperate with police officers
• carry valid ID at all times and be prepared for various checkpoints
• monitor local news to stay informed on the current situation

A nightly curfew is in effect in Ouest Department from 10 pm to 5 am. You must stay indoors while the curfew is in effect. There are exceptions for certain professions, including medical personnel and journalists carrying official identification.

Your personal safety is at risk if you are currently in Haiti. You should consider leaving the country by commercial means if you can do so safely.

There are two international airports in the country which can be difficult to access due to the highly volatile security situation. The Toussaint Louverture International Airport has reopened although with limited operations. The Cap Haitian International Airport is operational.

We strongly advise against any road travel from Port-au-Prince to Cap-Haitien, given the presence of gangs and a highly volatile security situation.

Avoid all travel to Haiti. If you are in Haiti despite this advisory:

• shelter in a safe place until the situation has stabilized
• consider leaving the country if there's a safe means to do so
• ensure that you have essential supplies, including food, water and fuel
• ensure that your passport and other travel documents are up-to-date and secure at all times
• limit your movements, if you are unable to shelter in place
• avoid crossing road blockades, even if they appear unattended
• allow extra time to reach your destination
• be aware of your surroundings at all times
• maintain a low profile when going outside
• don't show signs of affluence
• register or update your personal information through the Registration of Canadians Abroad service and encourage other Canadian citizens in Haiti to do so

Canadian citizens in Haiti must register with Global Affairs Canada and contact the Emergency Watch and Response Centre if they require consular assistance.

Declaration of the state of emergency – Ministry of Communication of Haiti (in French)

Border closure with the Dominican Republic

On March 5, 2024, the Government of the Dominican Republic closed its air border with Haiti. Land and sea borders between the two countries remain closed to travellers.

The Embassy of Canada to Haiti, in Port-au-Prince, cannot help you enter the Dominican Republic from Haiti.

Crime rates are high in large centres such as downtown Port-au-Prince, where armed gangs operate, as well as near the border with the Dominican Republic.

The number of violent incidents has been increasing since 2020, especially kidnappings in and around Port-au-Prince.

There has also been an increase in home invasions. These incidents generally occur in middle-class neighbourhoods, but have increased in number in affluent neighbourhoods in Port-au-Prince and outside Pétion-Ville.

Petty crime, such as pickpocketing and purse snatching, also occurs.

Criminality increases in the periods leading up to the holiday season in December, Carnival in February or March and the beginning of the school year in late August or early September.

Foreigners are viewed as wealthy and may arouse envy. To avoid becoming a target:

• don’t show signs of affluence
• avoid using your smartphone or camera in public
• be aware of your surroundings
• ensure that your personal belongings, including your passport and other travel documents, are secure at all times
• remain cautious with new acquaintances offering friendship or hospitality
• never walk alone and avoid travelling after nightfall

Greater Port-au-Prince area

Several areas in greater Port-au-Prince continue to be dangerous due to criminal activity and kidnappings. Local authorities may have difficulties assisting during an emergency in these areas:

• Artibonite Central
• Carrefour Drouillard
• Champs-de-Mars
• Cité Soleil
• Croix-des-Bouquets
• Downtown Port-au-Prince
• Portail Léogane
• Road to the airport
• Toussant Brave

Police presence is not guaranteed in these areas and your personal safety might be at risk. Due to the local environment, security forces may not be able to provide emergency assistance in due time.

If you must travel to these areas, it’s imperative that you take appropriate security precautions:

• be vigilant at all times when moving about the city, towns and country
• ensure that your local contacts know when to expect you and your travel plans within these areas
• ask your local contacts to guide you in your travels
• keep windows closed and doors locked when travelling by car
• never use public transport of any kind
• ask the organizations, institutes or hosts that are taking care of you about the latest updates on the region to which you are travelling, since the security situation can change at any moment
• avoid going out after nightfall
• follow the advice of local authorities

Pétion-Ville

Armed robberies occur regularly in Pétion-Ville. In most cases, armed thieves on motorcycles attack their victims in broad daylight. Attacks have been increasing, particularly against motorists. They usually occur in traffic jams during peak hours.

• Be vigilant at all times while travelling
• Keep windows closed and doors locked when travelling by car

Main highways and roads

Armed gangs have set up roadblocks to commit robberies and demand payments along Route Nationale 2 from Martissant to Miragoane.

Armed gangs are fighting to control the main highways connecting Port-au-Prince to northern departments.

If you must drive:

• limit your movements

Toussaint Louverture International Airport

Thieves try to distract foreigners to steal their passports at Toussaint Louverture International Airport.

• Be cautious when claiming your luggage upon arrival
• Keep your valuables and identification on you
• Have your local contacts arrange for your pick-up from the airport
• Carry only small amounts of cash

Several shooting incidents have also occurred along the road to the airport. Gangs have committed armed robberies, particularly between Delmas 33 and the airport.

• Don’t resist if you’re threatened by robbers
• Be extremely vigilant when leaving the airport

Border with the Dominican Republic

The security environment is highly volatile at the border between Haiti and the Dominican Republic.

Criminal activities are widespread near the border with the Dominican Republic. Armed gangs operate along the border controlling many of the roads leading to the border.

Border areas with the Dominican Republic are subject to gang operations, including the following areas:

• Ouanaminthe

Robberies in bank areas

Some criminals wait near banks, watching clients, and attempt to rob them when they leave.

There is also a higher risk of robbery from individuals using bank ATMs.

• Be extremely vigilant when entering or leaving a bank
• Only use ATMs inside a hotel or supermarket
• Deal directly with a teller if you are at a bank
• Avoid carrying large sums of money

Kidnappings are common in Haiti.

Kidnappers target both local people and foreigners, including dual citizens who live or travel in Haiti, regardless of rank or social class. Since September 2020, hundreds of Canadians and other foreign nationals have been abducted. Missionaries, aid workers and children can become victims. Most of the victims are released in exchange for ransom. In some exceptional cases, however, victims have disappeared or have been killed.

• Remain alert to small groups of loiterers, especially near your residence
• Keep doors and windows secure at all times
• Instruct domestic staff to permit into your home only pre-authorized visitors whose identities have been verified
• Keep all visitors under close scrutiny
• Remain extremely vigilant wherever you are in the country

Demonstrations

Demonstrations and civil unrest take place frequently.

Due to ongoing political instability, some demonstrations have turned violent. Protesters have set up roadblocks across the country and blocked the access to the airport. In those circumstances, water, food and fuel shortages could occur.

Even peaceful demonstrations can turn violent at any time. They can also lead to disruptions to traffic and public transportation.

• Avoid areas where demonstrations and large gatherings are taking place
• Follow the instructions of local authorities
• Monitor local media for information on ongoing demonstrations

Mass gatherings (large-scale events)

Women’s safety

Crimes committed against women frequently occur in Haiti. Reports of rape and assault against women and children have increased. Attackers sometimes act in groups.

Advice for women travellers

Service outages and supply shortages

Power outages are frequent, and shortages of essential supplies such as water and fuel occur.

Ensure that you plan adequately in case of outages and supply shortages.

Road safety

Road conditions and road safety are poor throughout the country due to:

• narrow and poorly maintained roads
• insufficient traffic signs, traffic lights and road markings
• high rates of driving while impaired, with the vehicle’s lights off
• poor vehicle maintenance
• inadequate street lighting

Heavy rains can hamper overland travel and reduce the provision of essential services. Roads may become impassable and bridges damaged.

If you need to travel within Haiti, consider hiring a driver through a reputable agency or hotel. If you must drive:

• always keep your fuel tanks at least half full, as disruptions of fuel supplies are frequent
• always carry a cell phone and a list of emergency contact numbers with you, as roadside assistance services are deficient
• keep in mind that cell phone coverage may be intermittent in some rural areas
• avoid driving at night or in bad weather, even in the city
• be cautious about abandoned vehicle beside the road
• watch out for pedestrians and stray animals on the road

Public transportation

Public transportation is unsafe and unreliable. Drivers don’t always respect traffic laws. Vehicles are often in poor condition or overloaded, which leads to serious accidents involving injuries and sometimes death.

You should avoid all public transportation in Haiti, but most specifically trucks converted into buses, known as “tap taps.”

Ferry accidents occur and are often caused by poor safety practices or extreme weather conditions.

You should avoid ferry travel. If you choose to travel by ferry:

• make sure the vessel you are boarding is carrying appropriate safety equipment
• make sure that life jackets are provided for all passengers and accessible at all times
• avoid boarding vessels that appear overloaded or unseaworthy
• verify the safety standards of ferries with your tour operator

We do not make assessments on the compliance of foreign domestic airlines with international safety standards.

Information about foreign domestic airlines

Every country or territory decides who can enter or exit through its borders. The Government of Canada cannot intervene on your behalf if you do not meet your destination’s entry or exit requirements.

We have obtained the information on this page from the Haitian authorities. It can, however, change at any time.

Verify this information with the  Foreign Representatives in Canada .

Entry requirements vary depending on the type of passport you use for travel.

Before you travel, check with your transportation company about passport requirements. Its rules on passport validity may be more stringent than the country’s entry rules.

Regular Canadian passport

Your passport must be valid for the expected duration of your stay in Haiti.

Passport for official travel

Different entry rules may apply.

Official travel

Passport with “X” gender identifier

While the Government of Canada issues passports with an “X” gender identifier, it cannot guarantee your entry or transit through other countries. You might face entry restrictions in countries that do not recognize the “X” gender identifier. Before you leave, check with the closest foreign representative for your destination.

Other travel documents

Different entry rules may apply when travelling with a temporary passport or an emergency travel document. Before you leave, check with the closest foreign representative for your destination.

Useful links

• Foreign Representatives in Canada
• Canadian passports

Tourist visa: not required for stays up to 90 days Business visa: not required Student visa: required Work permit: required

Residency permit

You must obtain a residency permit if you intend to stay for 90 days or more. This requirement doesn’t apply to Canadians of Haitian origin.

If you plan to extend your stay beyond 90 days and are a Canadian of non-Haitian origin, you must apply to the Haitian Immigration Service before the 90 days have expired. If you fail to do so, you will need an exit visa to leave the country.

Canadian investors, exporters/importers and workers must apply to the Haitian Immigration Service for a residency permit through their employer for stays of 6 months or more. You must obtain this document before leaving Canada.

How to obtain a visa - Embassy of Haiti in Canada (in French)

Other entry requirements

Customs officials may ask you to show them a return or onward ticket and proof of sufficient funds to cover your stay.

• Children and travel

Learn more about travelling with children .

Yellow fever

Learn about potential entry requirements related to yellow fever (vaccines section).

Relevant Travel Health Notices

• Global Measles Notice - 13 March, 2024
• Zika virus: Advice for travellers - 31 August, 2023
• COVID-19 and International Travel - 13 March, 2024

This section contains information on possible health risks and restrictions regularly found or ongoing in the destination. Follow this advice to lower your risk of becoming ill while travelling. Not all risks are listed below.

Consult a health care professional or visit a travel health clinic preferably 6 weeks before you travel to get personalized health advice and recommendations.

Routine vaccines

Be sure that your  routine vaccinations , as per your province or territory , are up-to-date before travelling, regardless of your destination.

Some of these vaccinations include measles-mumps-rubella (MMR), diphtheria, tetanus, pertussis, polio, varicella (chickenpox), influenza and others.

Pre-travel vaccines and medications

You may be at risk for preventable diseases while travelling in this destination. Talk to a travel health professional about which medications or vaccines may be right for you, based on your destination and itinerary. 

Yellow fever   is a disease caused by a flavivirus from the bite of an infected mosquito.

Travellers get vaccinated either because it is required to enter a country or because it is recommended for their protection.

• There is no risk of yellow fever in this country.

Country Entry Requirement*

• Proof of vaccination is required if you are coming from a country   where yellow fever occurs.

Recommendation

• Vaccination is not recommended.
• Discuss travel plans, activities, and destinations with a health care professional.
• Contact a designated  Yellow Fever Vaccination Centre  well in advance of your trip to arrange for vaccination.

About Yellow Fever

Yellow Fever Vaccination Centre

* It is important to note that  country entry requirements  may not reflect your risk of yellow fever at your destination. It is recommended that you contact the nearest  diplomatic or consular office  of the destination(s) you will be visiting to verify any additional entry requirements.

There is a risk of hepatitis A in this destination. It is a disease of the liver. People can get hepatitis A if they ingest contaminated food or water, eat foods prepared by an infectious person, or if they have close physical contact (such as oral-anal sex) with an infectious person, although casual contact among people does not spread the virus.

Practise  safe food and water precautions and wash your hands often. Vaccination is recommended for all travellers to areas where hepatitis A is present.

Measles is a highly contagious viral disease. It can spread quickly from person to person by direct contact and through droplets in the air.

Anyone who is not protected against measles is at risk of being infected with it when travelling internationally.

Regardless of where you are going, talk to a health care professional before travelling to make sure you are fully protected against measles.

  Hepatitis B is a risk in every destination. It is a viral liver disease that is easily transmitted from one person to another through exposure to blood and body fluids containing the hepatitis B virus.  Travellers who may be exposed to blood or other bodily fluids (e.g., through sexual contact, medical treatment, sharing needles, tattooing, acupuncture or occupational exposure) are at higher risk of getting hepatitis B.

Hepatitis B vaccination is recommended for all travellers. Prevent hepatitis B infection by practicing safe sex, only using new and sterile drug equipment, and only getting tattoos and piercings in settings that follow public health regulations and standards.

Coronavirus disease (COVID-19) is an infectious viral disease. It can spread from person to person by direct contact and through droplets in the air.

It is recommended that all eligible travellers complete a COVID-19 vaccine series along with any additional recommended doses in Canada before travelling. Evidence shows that vaccines are very effective at preventing severe illness, hospitalization and death from COVID-19. While vaccination provides better protection against serious illness, you may still be at risk of infection from the virus that causes COVID-19. Anyone who has not completed a vaccine series is at increased risk of being infected with the virus that causes COVID-19 and is at greater risk for severe disease when travelling internationally.

Before travelling, verify your destination’s COVID-19 vaccination entry/exit requirements. Regardless of where you are going, talk to a health care professional before travelling to make sure you are adequately protected against COVID-19.

 The best way to protect yourself from seasonal influenza (flu) is to get vaccinated every year. Get the flu shot at least 2 weeks before travelling.  

 The flu occurs worldwide. 

•  In the Northern Hemisphere, the flu season usually runs from November to   April.
•  In the Southern Hemisphere, the flu season usually runs between April and   October.
•  In the tropics, there is flu activity year round. 

The flu vaccine available in one hemisphere may only offer partial protection against the flu in the other hemisphere.

The flu virus spreads from person to person when they cough or sneeze or by touching objects and surfaces that have been contaminated with the virus. Clean your hands often and wear a mask if you have a fever or respiratory symptoms.

Malaria is a serious and sometimes fatal disease that is caused by parasites spread through the bites of mosquitoes.

Malaria is a risk to travellers to this destination.   Antimalarial medication is recommended for most travellers to this destination and should be taken as recommended. Consult a health care professional or visit a travel health clinic before travelling to discuss your options. It is recommended to do this 6 weeks before travel, however, it is still a good idea any time before leaving.    Protect yourself from mosquito bites at all times: 

• Cover your skin and use an approved insect repellent on uncovered skin.
• Exclude mosquitoes from your living area with screening and/or closed, well-sealed doors and windows.
• Use insecticide-treated bed nets if mosquitoes cannot be excluded from your living area.
• Wear permethrin-treated clothing. 

 If you develop symptoms similar to malaria when you are travelling or up to a year after you return home, see a health care professional immediately. Tell them where you have been travelling or living. 

In this destination, rabies is commonly carried by dogs and some wildlife, including bats. Rabies is a deadly disease that spreads to humans primarily through bites or scratches from an infected animal. While travelling, take precautions , including keeping your distance from animals (including free-roaming dogs), and closely supervising children.

If you are bitten or scratched by a dog or other animal while travelling, immediately wash the wound with soap and clean water and see a health care professional. In this destination, rabies treatment may be limited or may not be available, therefore you may need to return to Canada for treatment.  

Before travel, discuss rabies vaccination with a health care professional. It may be recommended for travellers who are at high risk of exposure (e.g., occupational risk such as veterinarians and wildlife workers, children, adventure travellers and spelunkers, and others in close contact with animals). 

Safe food and water precautions

Many illnesses can be caused by eating food or drinking beverages contaminated by bacteria, parasites, toxins, or viruses, or by swimming or bathing in contaminated water.

• Learn more about food and water precautions to take to avoid getting sick by visiting our eat and drink safely abroad page. Remember: Boil it, cook it, peel it, or leave it!
• Avoid getting water into your eyes, mouth or nose when swimming or participating in activities in freshwater (streams, canals, lakes), particularly after flooding or heavy rain. Water may look clean but could still be polluted or contaminated.
• Avoid inhaling or swallowing water while bathing, showering, or swimming in pools or hot tubs. 

Cholera is a risk in parts of this country. Most travellers are at very low risk.

To protect against cholera, all travellers should practise safe food and water precautions .

Travellers at higher risk of getting cholera include those:

• visiting, working or living in areas with limited access to safe food, water and proper sanitation
• visiting areas where outbreaks are occurring

Vaccination may be recommended for high-risk travellers, and should be discussed with a health care professional.

Travellers' diarrhea is the most common illness affecting travellers. It is spread from eating or drinking contaminated food or water.

Risk of developing travellers' diarrhea increases when travelling in regions with poor standards of hygiene and sanitation. Practise safe food and water precautions.

The most important treatment for travellers' diarrhea is rehydration (drinking lots of fluids). Carry oral rehydration salts when travelling.

Typhoid   is a bacterial infection spread by contaminated food or water. Risk is higher among children, travellers going to rural areas, travellers visiting friends and relatives or those travelling for a long period of time.

Travellers visiting regions with a risk of typhoid, especially those exposed to places with poor sanitation, should speak to a health care professional about vaccination.  

Insect bite prevention

Many diseases are spread by the bites of infected insects such as mosquitoes, ticks, fleas or flies. When travelling to areas where infected insects may be present:

• Use insect repellent (bug spray) on exposed skin
• Cover up with light-coloured, loose clothes made of tightly woven materials such as nylon or polyester
• Minimize exposure to insects
• Use mosquito netting when sleeping outdoors or in buildings that are not fully enclosed

To learn more about how you can reduce your risk of infection and disease caused by bites, both at home and abroad, visit our insect bite prevention page.

Find out what types of insects are present where you’re travelling, when they’re most active, and the symptoms of the diseases they spread.

There is a risk of chikungunya in this country.  The risk may vary between regions of a country.  Chikungunya is a virus spread through the bite of an infected mosquito. Chikungunya can cause a viral disease that typically causes fever and pain in the joints. In some cases, the joint pain can be severe and last for months or years.

Protect yourself from mosquito bites at all times. There is no vaccine available for chikungunya.

• In this country,   dengue  is a risk to travellers. It is a viral disease spread to humans by mosquito bites.
• Dengue can cause flu-like symptoms. In some cases, it can lead to severe dengue, which can be fatal.
• The level of risk of dengue changes seasonally, and varies from year to year. The level of risk also varies between regions in a country and can depend on the elevation in the region.
• Mosquitoes carrying dengue typically bite during the daytime, particularly around sunrise and sunset.
• Protect yourself from mosquito bites . There is no vaccine or medication that protects against dengue.

Zika virus is a risk in this country. 

Zika virus is primarily spread through the bite of an infected mosquito. It can also be sexually transmitted. Zika virus can cause serious birth defects.

During your trip:

• Prevent mosquito bites at all times.
• Use condoms correctly or avoid sexual contact, particularly if you are pregnant.

If you are pregnant or planning a pregnancy, you should discuss the potential risks of travelling to this destination with your health care provider. You may choose to avoid or postpone travel. 

For more information, see Zika virus: Pregnant or planning a pregnancy.

Animal precautions

Some infections, such as rabies and influenza, can be shared between humans and animals. Certain types of activities may increase your chance of contact with animals, such as travelling in rural or forested areas, camping, hiking, and visiting wet markets (places where live animals are slaughtered and sold) or caves.

Travellers are cautioned to avoid contact with animals, including dogs, livestock (pigs, cows), monkeys, snakes, rodents, birds, and bats, and to avoid eating undercooked wild game.

Closely supervise children, as they are more likely to come in contact with animals.

Person-to-person infections

Stay home if you’re sick and practise proper cough and sneeze etiquette , which includes coughing or sneezing into a tissue or the bend of your arm, not your hand. Reduce your risk of colds, the flu and other illnesses by:

•   washing your hands often
• avoiding or limiting the amount of time spent in closed spaces, crowded places, or at large-scale events (concerts, sporting events, rallies)
• avoiding close physical contact with people who may be showing symptoms of illness 

Sexually transmitted infections (STIs) , HIV , and mpox are spread through blood and bodily fluids; use condoms, practise safe sex, and limit your number of sexual partners. Check with your local public health authority pre-travel to determine your eligibility for mpox vaccine.  

Tuberculosis is an infection caused by bacteria and usually affects the lungs.

For most travellers the risk of tuberculosis is low.

Travellers who may be at high risk while travelling in regions with risk of tuberculosis should discuss pre- and post-travel options with a health care professional.

High-risk travellers include those visiting or working in prisons, refugee camps, homeless shelters, or hospitals, or travellers visiting friends and relatives.

HIV (Human Immunodeficiency Virus)   is a virus that attacks and impairs the immune system, resulting in a chronic, progressive illness known as AIDS (Acquired Immunodeficiency Syndrome). 

High risk activities include anything which puts you in contact with blood or body fluids, such as unprotected sex and exposure to unsterilized needles for medications or other substances (for example, steroids and drugs), tattooing, body-piercing or acupuncture.

Medical services and facilities

Health care is inadequate throughout the country. There are few hospitals, and many are closed. Clinics and hospitals that are open are easily overwhelmed. Hospital services can be disrupted by gang violence

Ambulances are also limited and may not have the basic required medical supplies onboard. As a result, emergency response is not guaranteed.

Physicians and hospitals generally expect immediate cash payment for care even if you have proof of valid travel health insurance. You will have to pay the full amount of the bill before your departure.

Medications sold in Haiti may be of inferior quality to those available in Canada. Pharmacies may carry expired medications while some medications may simply not be available.

Bring a sufficient supply of medications for the duration of your stay.

Medical evacuation can be very expensive and you may need it in case of serious illness or injury.

Make sure you get travel insurance that includes coverage for medical evacuation and hospital stays.

Travel health and safety

Keep in Mind...

The decision to travel is the sole responsibility of the traveller. The traveller is also responsible for his or her own personal safety.

Be prepared. Do not expect medical services to be the same as in Canada. Pack a   travel health kit , especially if you will be travelling away from major city centres.

You must abide by local laws.

Learn about what you should do and how we can help if you are arrested or detained abroad .

Legal fees can be very high and judicial procedures are slow. Some Canadians have experienced an over a year detention period before being sent to trial. Prison conditions are extremely difficult. Penal facilities are overcrowded, unsanitary and under-resourced.

Penalties for possession, use or trafficking of illegal drugs are severe. Convicted offenders can expect lengthy legal proceedings, heavy jail sentences and fines.

Drugs, alcohol and travel

Dual citizenship

Dual citizenship is legally recognized in Haiti.

If you are a Canadian citizen, but also a citizen of Haiti, our ability to offer you consular services may be limited while you're there. You may also be subject to different entry/exit requirements .

Travellers with dual citizenship

International Child Abduction

The Hague Convention on the Civil Aspects of International Child Abduction is an international treaty. It can help parents with the return of children who have been removed to or retained in certain countries in violation of custody rights. It does not apply between Canada and Haiti.

If your child was wrongfully taken to, or is being held in Haiti by an abducting parent:

• act as quickly as you can
• consult a lawyer in Canada and in Haiti to explore all the legal options for the return of your child
• report the situation to the nearest Canadian government office abroad or to the Vulnerable Children's Consular Unit at Global Affairs Canada by calling the Emergency Watch and Response Centre

If your child was removed from a country other than Canada, consult a lawyer to determine if The Hague Convention applies.

Be aware that Canadian consular officials cannot interfere in private legal matters or in another country's judicial affairs.

• International Child Abductions: A guide for affected parents
• Canadian embassies and consulates by destination
• Request emergency assistance

2SLGBTQI+ travellers

Haitian law does not prohibit sexual acts between individuals of the same sex.

However, 2SLGBTQI+ travellers could be discriminated against based on their sexual orientation, gender identity, gender expression or sex characteristics.

Travel and your sexual orientation, gender identity, gender expression and sex characteristics

In order to fight insecurity, local authorities have temporarily forbidden to drive vehicles with tinted windows throughout the country.

You may use your Canadian driver’s licence to drive in Haiti for up to 3 months. For stays of 3 months or more, you will require a Haitian driver’s permit.

You should carry an international driving permit.

International Driving Permit

Photography

People may feel exploited or insulted by being subjects of photography in poor or urban areas.

Obtain permission before photographing individuals.

Donations entering the country are subject to import rules. They could be seized and taxed in accordance with local legislation. This includes:

• new or used material goods
• personal care products
• medications

Contact the Embassy of the Republic of Haiti or one of its consulates before sending goods to Haiti.

The currency in Haiti is the Haitian gourde (HTG).

Although all prices should be in gourde since March 2018, they are still often quoted in Haitian dollars (5 gourdes = 1 Haitian dollar) or in U.S. dollars.

Canadian currency is not accepted. Most leading hotels accept major credit cards. You can also use your Canadian bank cards to access funds from some ATMs, but the withdrawal limit is much lower than in Canada. Haitian ATMs are unreliable and you should not depend upon them in emergency situations.

Make sure to have sufficient cash in case you’re unable to access an ATM or use your credit card.

Hurricane Beryl

Hurricane Beryl is expected to sweep across the south coast of Haiti, from the border of the Dominican Republic to Anse d’Hainault, on July 2, 2024.

The storm is likely to bring excessive rainfall and violent winds. It may cause flash flooding and landslides and could severely disrupt the following essential services:

• transportation
• power distribution
• water and food supply
• telecommunications networks
• emergency services
• medical care

Avoid all travel to the affected areas. If you are in the affected areas:

• exercise caution
• monitor local news and weather reports

Latest advisories  – U.S. National Hurricane centre

Hurricane season

Hurricanes usually occur from mid-May to the end of November. During this period, even small tropical storms can quickly develop into major hurricanes.

These severe storms can put you at risk and hamper the provision of essential services.

If you decide to travel to Haiti during the hurricane season:

• know that you expose yourself to serious safety risks
• be prepared to change your travel plans on short notice, including cutting short or cancelling your trip
• stay informed of the latest regional weather forecasts
• carry emergency contact information for your airline or tour operator
• follow the advice and instructions of local authorities
• Tornadoes, cyclones, hurricanes, typhoons and monsoons
• Large-scale emergencies abroad
• Active storm tracking and hurricane watches and warnings  - United States National Hurricane Center

Rainy season  

The rainy season extends from April to June and from October to November. It can lead to severe flooding.

Seasonal flooding can hamper overland travel and reduce the provision of essential services. Roads may become impassable due to mudslides and landslides. Bridges, buildings, and infrastructure may be damaged. 

• Monitor local media for the latest updates, including those on road conditions 
• Stay away from flooded areas 
• Monitor weather reports 
• Follow the instructions of local authorities, including evacuation orders 

Earthquakes and tsunamis

Haiti is located in an active seismic zone. Earthquakes occur. Tsunamis can also affect coastal areas.

A tsunami can occur within minutes of a nearby earthquake. However, the risk of tsunami can remain for several hours following the first tremor. If you’re staying on the coast, familiarize yourself with the region’s evacuation plans in the event of a tsunami warning.

In the event of an earthquake:

• monitor local media for the latest information
• Earthquakes - What to Do?
• Tsunami alerts  - U.S. Tsunami Warning System
• Latest earthquakes  - U.S. Geological Survey

Local services

In case of emergency, dial 114.

Consular assistance

For emergency consular assistance, call the Embassy of Canada to Haiti, in Port-au-Prince, and follow the instructions. At any time, you may also call the Emergency Watch and Response Centre in Ottawa.

The decision to travel is your choice and you are responsible for your personal safety abroad. We take the safety and security of Canadians abroad very seriously and provide credible and timely information in our Travel Advice to enable you to make well-informed decisions regarding your travel abroad.

The content on this page is provided for information only. While we make every effort to give you correct information, it is provided on an "as is" basis without warranty of any kind, expressed or implied. The Government of Canada does not assume responsibility and will not be liable for any damages in connection to the information provided.

If you need consular assistance while abroad, we will make every effort to help you. However, there may be constraints that will limit the ability of the Government of Canada to provide services.

Learn more about consular services .

Risk Levels

  take normal security precautions.

Take similar precautions to those you would take in Canada.

  Exercise a high degree of caution

There are certain safety and security concerns or the situation could change quickly. Be very cautious at all times, monitor local media and follow the instructions of local authorities.

IMPORTANT: The two levels below are official Government of Canada Travel Advisories and are issued when the safety and security of Canadians travelling or living in the country or region may be at risk.

  Avoid non-essential travel

Your safety and security could be at risk. You should think about your need to travel to this country, territory or region based on family or business requirements, knowledge of or familiarity with the region, and other factors. If you are already there, think about whether you really need to be there. If you do not need to be there, you should think about leaving.

  Avoid all travel

You should not travel to this country, territory or region. Your personal safety and security are at great risk. If you are already there, you should think about leaving if it is safe to do so.

We’re sorry, this site is currently experiencing technical difficulties. Please try again in a few moments. Exception: request blocked

Protecting Health in Haiti Amid Crisis

In today’s interconnected world, it is more critical than ever to strengthen and preserve global health systems to prevent, detect and respond to disease outbreaks. However, despite steps taken to respond to the COVID-19 pandemic, the world is not yet prepared to meet future epidemic and pandemic threats. According to the 2021 Global Health Security Index, all countries remain dangerously unprepared for future epidemic and pandemic threats, and 70% lack the necessary capacity in clinics, hospitals, and community care centers. With the rise of zoonotic and drug resistant pathogens, these gaps make us all even more vulnerable.

Environmental disasters and armed conflict represent some of the biggest ongoing threats to global health security. In recent years, the already fragile health systems of Haiti have been devastated by both.

In August 2021, a 7.2 magnitude earthquake struck southwestern Haiti, killing more than 2,240 people and injuring approximately 12,700 others, just one month after the country was thrown into political turmoil by the assassination of President Jovenel Moïse. Today, Haiti continues to face armed violence and political instability that are disrupting regional public health efforts. Lack of fuel and ongoing safety concerns have prevented the deployment of healthcare workers and resources to many high-need areas, and many hospitals are closed or are operating at an extremely limited capacity.

For over ten years, the CDC Foundation has been working with our international partners to support and strengthen Haiti’s capacity to monitor and address health crises. When an earthquake struck Haiti in 2010, killing over 200,000 people and destroying Haiti’s Ministry of Public Health and Population (MSPP) building, the CDC Foundation supported reconstruction of two vital MSPP health facilities and has continued working with MSPP to monitor and control disease outbreaks and establish critical health infrastructure and outreach.

The Petionville community of Port au Prince, which was heavily damaged by the 2010 earthquake

The Ministry of Public Health and Population in downtown Port au Prince which were completely destroyed in the 2010 earthquake

CDC Foundation support allowed for construction of new buildings for the Ministry of Public Health and Population

Today, reinstating Haiti’s water systems after the 2021 earthquake is a top priority. Access to water, sanitation and hygiene (WASH) is essential to prevent waterborne diseases, and Haiti’s current cholera outbreak reflects the urgency of this work. The CDC Foundation and our partners at the Centers for Disease Control and Prevention (CDC), UNICEF and MSPP are rehabilitating preexisting water and sanitation infrastructure by increasing water storage capacity, repairing handwashing stations and latrines and providing soap and critical hygiene supplies. We are also supporting education and promotion of hygiene practices in health facilities and schools.

“In the wake of the 2021 earthquake and Haiti’s ongoing insecurity, having a strong WASH infrastructure helps us reduce the risk of infection,” said Rebecca Cook, MPH, senior program officer at the CDC Foundation. “These systems improve prevention and control and better prepare us for outbreaks like cholera, COVID-19 and other infectious diseases.”

Residents in the village of Trianon, Haiti, gather water from a spring-fed water point.

Drinking water and sanitation technicians test spring water for chlorination.

Chemists work in an on-site lab in Port-au-Prince to produce chlorine bleach as part of efforts to fight cholera.

The ongoing environmental challenges and political upheaval in Haiti have also slowed national COVID-19 vaccination efforts. Despite a 2021 donation of 500,000 COVID-19 vaccines through COVAX, a global initiative to increase vaccination rates around the world, growing mistrust of the government and the spread of misinformation led to poor vaccination rates.

Community awareness is key. It's not particular to Haiti. It's everywhere. Get the word out. Use the appropriate channels, use their language.

To overcome these difficulties, CDC Foundation partners address misinformation and bolster vaccine confidence and awareness through risk communication, community engagement and information-sharing. From 2020-2021, Georgetown University supported Haiti’s pandemic response by gathering data on public perspectives, attitudes and beliefs related to COVID-19 infection and vaccination, subsequently increasing vaccination rates.

An MSPP sign displaying COVID-19 health measures

Community health workers provide COVID-19 vaccinations to communities

Facing limited power supply, a health worker uses his phone to fill out forms

Our partners at Fondation pour la Santé Reproductrice et l’Education Familiale (FOSREF) have built upon this work by delivering information about the safety and importance of vaccination via tv, radio, fliers and education programs. In response to rising safety concerns, FOSREF created mobile vaccine teams to increase vaccine access, especially among women and people living with HIV.

“Community awareness is key. It's not particular to Haiti. It's everywhere. Get the word out. Use the appropriate channels, use their language,” said Johane Philogène Nonez MD, MSc., technical and program director at FORSEF.

Guided by community voices, the CDC Foundation and its partners will continue to mobilize resources for emergency response and preparedness in Haiti’s health systems. As we continue our efforts to bolster health security in Haiti and around the world, we must remember that no community, district, province or nation will be truly safe and healthy until all are.

Banner Photo Credit: UNICEF Haiti/2022/Grarup

This publication is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $3,980,000 with 86.5% funded by CDC/HHS and $620,400 or 13.5% funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Increased Risk of Dengue Virus Infections in the United States

Distributed via the CDC Health Alert Network June 25, 2024, 2:30 PM ET CDCHAN-00511

Summary The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to notify healthcare providers, public health authorities and the public of an increased risk of dengue virus (DENV) infections in the United States in 2024. Global incidence of dengue in 2024 has been the highest on record for this calendar year; many countries are reporting higher-than-usual dengue case numbers . In 2024, countries in the Americas have reported a record-breaking number of dengue cases, exceeding the highest number ever recorded in a single year. From January 1 – June 24, 2024, countries in the Americas reported more than 9.7 million dengue cases, twice as many as in all of 2023 (4.6 million cases). In the United States, Puerto Rico has declared a public health emergency (1,498 cases) and a higher-than-expected number of dengue cases have been identified among U.S. travelers (745 cases) from January 1 – June 24, 2024. In the setting of increased global and domestic incidence of dengue, healthcare providers should take steps including:

• Have increased suspicion of dengue among people with fever who have been in areas with frequent or continuous dengue transmission within 14 days before illness onset,
• Order appropriate diagnostic tests for acute DENV infection: reverse transcription polymerase chain reaction [RT-PCR] and IgM antibody tests, or non-structural protein 1 [NS1] antigen tests and IgM antibody tests,
• Ensure timely reporting of dengue cases to public health authorities, and
• Promote mosquito bite prevention measures among people living in or visiting areas with frequent or continuous dengue transmission.

Background Dengue is the most common arboviral disease globally. It is caused by four distinct but closely related dengue viruses (DENV-1, -2, -3, and -4). DENVs are transmitted through bites of infected Aedes species mosquito vectors. Infection with one DENV generally induces life-long protection against infection from that specific DENV but only protects against other DENVs for several months to years. Dengue is a nationally notifiable disease in the United States. Six U.S. territories and freely associated states are classified as areas with frequent or continuous dengue transmission : Puerto Rico, American Samoa, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of Marshall Islands, and the Republic of Palau. In the rest of the United States, local transmission of DENV has been limited, with sporadic cases or small outbreaks in Florida, Hawaii, and Texas. However, confirmed local DENV transmission has also been reported by Arizona and California over the past two years.

Approximately one in four DENV infections are symptomatic and can be mild or severe. Symptoms begin after an incubation period of 5–7 days (range 3–10 days) and present as fever accompanied by non-specific signs and symptoms such as nausea, vomiting, rash, muscle aches, joint pain, bone pain, pain behind the eyes, headache, or low white blood cell counts. Warning signs are specific clinical findings that predict progression to severe disease. Warning signs include abdominal pain or tenderness, persistent vomiting, clinical fluid accumulation (e.g., ascites, pleural effusion), mucosal bleeding, lethargy or restlessness, progressive increase of hematocrit, or liver enlargement >2cm. Severe disease, with associated severe bleeding, shock or respiratory distress caused by plasma leakage, or end-organ impairment, develops in 1 in 20 people with symptomatic dengue. Infants aged ≤1 year, pregnant people, adults aged ≥65 years, and people with certain medical conditions are at increased risk of severe dengue. Although a second DENV infection (i.e., with a different DENV from the first infection) carries a higher risk of severe disease than a first, third, or fourth infection, any infection can lead to severe disease.

Patients with symptoms compatible with dengue can be tested with both molecular and serologic diagnostic tests. All patients with suspected DENV infection should be tested with RT-PCR (i.e., a nucleic acid amplification test (NAAT)) or a NS1 antigen test, and also with IgM antibody test to confirm DENV infection. These tests can be considered regardless of the symptom onset date, although the test sensitivity of RT-PCR and NS1 antigen tests decrease after the first 7 days. IgG detection by enzyme-linked immunosorbent assay (ELISA) in a single serum sample should not be used to diagnose a patient with acute dengue because it does not distinguish between current and previous DENV infection. U.S. Food and Drug Administration (FDA)-approved testing is available at public health laboratories and some commercial laboratories. State, tribal, territorial, and local health departments, and CDC can offer additional testing guidance.

There are no antiviral medications approved to treat dengue. Treatment is supportive and requires careful volume management. Appropriate triage, management, and follow-up remain the most effective interventions to reduce dengue morbidity and mortality. Expectant management of patients at high risk for severe disease and rapid initiation of a standardized fluid replacement strategy recommended by the World Health Organization (WHO) can decrease mortality from 13% to <1%. In June 2021, the Advisory Committee of Immunization Practices recommended a dengue vaccine, Dengvaxia , for children aged 9–16 years with laboratory confirmation of previous DENV infection and living in areas with frequent or continuous dengue transmission such as Puerto Rico. While the vaccine is considered safe and effective, the manufacturer (Sanofi Pasteur, Inc., Paris France) has discontinued production citing a lack of demand. Vaccine administration will continue in Puerto Rico until available doses expire in 2026.There are no vaccines recommended for travelers, adults, or persons without a previous DENV infection.

Dengue cases resurged globally after the COVID-19 pandemic. In 2023, more than 4.6 million cases and 4000 deaths were reported in the Americas region. As of June 24, 2024, more than 9.7 million dengue cases have been reported in the Americas, twice as many as in all of 2023 (4.6 million cases). Dengue transmission peaks during the warmer and wetter months in many tropical and subtropical regions. Dengue cases are likely to increase as global temperatures increase. Higher temperatures can expand the range of the mosquitoes that spread dengue, as well as affect other factors that facilitate virus transmission like faster viral amplification in the mosquito, increased vector survival, and changes in reproduction and biting rates. U.S. summer travel often overlaps with the months of increased dengue activity in many countries. Epidemics in the Americas region increase travel-associated cases and limited local transmission in the continental United States. A higher-than-expected number of dengue cases (total of 2,241 cases, including 1,498 in Puerto Rico) were reported in the United States from January 1 – June 24, 2024. Public health authorities in Puerto Rico declared a public health emergency in March 2024 because of the high number of cases reported during the low dengue season. Healthcare providers should be prepared to recognize, diagnose, manage, and report dengue cases to public health authorities; public health partners should investigate cases and disseminate clear prevention messages to the public. The CDC is actively implementing several strategies to address the increase in cases of dengue in the United States, including:

• Launching a program-led emergency response, which was activated on April 8, 2024.
• Providing regularly scheduled monthly situational updates on dengue to partners, stakeholders, and jurisdictions.
• Expanding laboratory capacity to improve laboratory testing approaches.
• Collaborating with State, Tribal, Local, and Territorial Health Departments to strengthen dengue surveillance and recommend prevention strategies.
• Educating the public on dengue prevention.

Recommendations for Healthcare Providers

• Maintain a high suspicion for dengue among patients with fever and recent travel (within 14 days before illness onset) to areas with frequent or continuous dengue transmission .
• Consider locally acquired dengue among patients who have signs and symptoms highly compatible with dengue (e.g., fever, thrombocytopenia, leukopenia, aches, pains, rash) in areas with competent mosquito vectors .
• Order appropriate FDA-approved dengue tests (RT-PCR and IgM antibody tests, or NS1 and IgM antibody tests), and do not delay treatment waiting for test results to confirm dengue.
• Know the warning signs for progression to severe dengue, which include abdominal pain or tenderness, persistent vomiting, clinical fluid accumulation, mucosal bleeding, lethargy or restlessness, and liver enlargement.
• For people with suspected dengue who do not have warning signs and are not part of a population at high risk for severe dengue, consider outpatient management with close follow-up.
• Teach patients about the warning signs that may appear as their fever starts to decline and instruct them to seek care urgently if they experience any warning signs.
• Recognize the critical phase of dengue. The critical phase begins when fever starts to decline and lasts for 24–48 hours. During this phase, some patients require close monitoring and may deteriorate within hours without appropriate intravenous (IV) fluid management.
• Hospitalize patients with severe dengue or any warning sign of progression to severe dengue and follow CDC/WHO protocols for IV fluid management .
• Follow local guidelines to report dengue cases to state, tribal, local, or territorial health departments.

Recommendations for State, Tribal, Local, and Territorial Health Departments

• Use FDA-approved dengue tests. Ensure access to dengue testing for all patients with suspected dengue.
• Remind clinicians of the high risk of dengue among patients with fever who have been in areas with frequent or continuous dengue transmission .
• Remind clinicians that local transmission can occur in areas with competent vectors and to test patients with compatible illnesses even without a history of having been in an area with dengue.
• Inform healthcare providers and the public when locally acquired and travel-associated dengue cases are detected in the area.
• Report dengue cases to CDC via ArboNET , the national arboviral surveillance system managed by CDC and state health departments.
• Take the lead in investigating dengue cases and outbreaks.
• Consider targeted outreach about increasing dengue risk to healthcare providers more likely to identify dengue cases (i.e., travel medicine clinics, infectious disease physicians, or healthcare systems serving highly mobile populations such as migrant and border health clinics, and clinics with frequent travelers to areas with frequent or continuous dengue transmission) and messaging to populations at higher risk for dengue.

Recommendations for the Public

• Use Environmental Protection Agency-approved repellents during travel to and after returning from areas with frequent or continuous dengue transmission.
• Wear loose-fitting, long-sleeved pants and shirts.
• Use air conditioning and window screens when possible, to lower risk for mosquito bites indoors.
• Dump and drain containers that hold water to reduce mosquito egg-laying sites in your home and neighborhood.
• Seek medical care if you have a fever or have dengue symptoms and live in or traveled to an area with dengue outbreaks .
• If you plan international travel to a an area with frequent or continuous dengue transmission , protect yourself from mosquito bites during and after your trip.

For More Information

Healthcare Providers

• Clinical Testing Guidance for Dengue | Dengue | CDC
• Guidelines for Classifying Dengue | Dengue | CDC
• Clinical Features of Dengue | Dengue | CDC
• Dengue Case Management Pocket Guide | CDC
• Dengue During Pregnancy | Dengue | CDC
• Dengue Vaccine | Dengue | CDC
• Dengvaxia: What Healthcare Professionals Need to Know | Dengue | CDC
• Dengue | CDC Yellow Book 2024
• Dengue Clinical Management Course | Dengue | CDC
• Webinar: What Clinicians Need to Know about Dengue in the United States | CDC

Health Departments and Public Health Professionals

• Data and Statistics on Dengue in the United States | Dengue | CDC
• What You Can Do to Control Mosquitoes During an Outbreak | Mosquitoes | CDC
• ArboNET | Mosquitoes | CDC
• Dengue case investigation report | CDC
• Dengue Print Resources | Dengue | CDC
• Communication Resources | Mosquitoes | CDC
• Submitting Specimens for Dengue Virus Tests | Vector-Borne Diseases | CDC
• Preventing Dengue | Dengue | CDC
• Caring for a Family Member with Dengue | CDC
• Mosquito Control at Home | Mosquitoes | CDC
• Get Rid of Mosquitos at Home | CDC
• Your Infant has Dengue | CDC
• Areas with Risk of Dengue | Dengue | CDC
• Travel Health Notices | Travelers’ Health | CDC
• Find a Clinic | Travelers’ Health | CDC
• Pan American Health Organization. Epidemiological Update Increase in dengue cases in the Region of the Americas. https://www.paho.org/en/documents/epidemiological-update-increase-dengue-cases-region-americas-18-june-2024
• Wong JM, Adams LE, Durbin AP, et al. Dengue: a growing problem with new interventions. Pediatrics . 2022;149(6):e2021055522. DOI: 10.1542/peds.2021-055522
• Paz-Bailey G, Adams L, Wong JM, et al. Dengue vaccine: recommendations of the Advisory Committee on Immunization Practices, United States, 2021. MMWR Recommendations and Reports . 2021;70(6):1–16. DOI: 10.15585/mmwr.rr7006a1 .
• World Health Organization. Disease Outbreak News; Dengue – Global situation. May 30, 2024.   https://www.who.int/emergencies/disease-outbreak-news/item/2024-DON518

The Centers for Disease Control and Prevention (CDC) protects people’s health and safety by preventing and controlling diseases and injuries; enhances health decisions by providing credible information on critical health issues; and promotes healthy living through strong partnerships with local, national and international organizations.

Department of Health and Human Services

Han message types.

• Health Alert: Conveys the highest level of importance about a public health incident.
• Health Advisory: Provides important information about a public health incident.
• Health Update: Provides updated information about a public health incident.

### This message was distributed to state and local health officers, state and local epidemiologists, state and local laboratory directors, public information officers, HAN coordinators, and clinician organizations. ###

• HAN Archive By Year
• Sign Up for HAN Email Updates
• HAN Jurisdictions
• Prepare Your Health
• Coping with a Disaster or Traumatic Event
• Information on Specific Types of Emergencies
• Information for Specific Groups
• Resources for Emergency Health Professionals
• Training & Education
• Social Media
• Preparation & Planning
• What CDC is Doing
• Blog: Public Health Matters

Exit Notification / Disclaimer Policy

• The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
• Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
• You will be subject to the destination website's privacy policy when you follow the link.
• CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.

Přejít k obsahu | Přejít k hlavnímu menu | Přejít k vyhledávání

• COVID-19 travel restrictions: Haiti
• < Travel restrictions

Travel restrictions

By Kiwi.com June 17, 2022

By Kiwi.com | June 17, 2022

This article was published on June 17, 2022, and all the information in the article is correct as of this time. Before you book your trip, we highly recommend that you also check official sources for the most up-to-date travel requirements, as they are subject to constant change.

Can I enter Haiti?

Haiti is open for tourism to travelers from all countries. Nevertheless, please note that several COVID-19 restrictions are in place now.

Can I enter Haiti if I am vaccinated? 

You can enter Haiti if you are vaccinated. You are considered fully vaccinated at least 14 days after the second dose of a two-dose vaccine, or at least 21 days after the administration of a single-dose vaccine. 

As of April 2022, the following vaccine drugs are approved in Haiti:

• Pfizer / BioNTech
• Moderna / Spikevax
• Janssen / Johnson & Johnson

Travel documents if you are vaccinated

• A vaccination certificate

Can I enter Haiti if I am unvaccinated? 

You can enter Haiti if you are unvaccinated. 

Travel documents if you are unvaccinated

Please present one of the following documents:

• The negative result of a PCR taken no more than 72 hours before departure
• Proof of recovery from COVID-19 in the last 90 days

Can I leave Haiti?

There are no COVID-19 restrictions when it comes to leaving Haiti. Please ensure that you are aware of the entry requirements at your destination country. Certain countries demand that travelers take pre-departure tests regardless of their vaccination status.

Can I leave Haiti if I am vaccinated?

Vaccinated travelers can leave Haiti.

• A COVID-19 vaccination certificate

Can I leave Haiti if I am unvaccinated?

There are no restrictions for unvaccinated travelers when it comes to leaving Haiti.

Unvaccinated travelers have to present one of the following documents: 

• Documentation of recovery from COVID-19, stating that the visitor was infected no longer ago than 180 days before the day of crossing the border of a particular country
• A negative COVID-19 test result (the relevant period and kind of test may vary, please check the requirements of your destination country )

COVID-19 situation in Haiti currently

Presently, the COVID-19 situation in Haiti is safe.

Is it safe to travel to Haiti right now?

International travel to Haiti is relatively safe now. Presently, some basic COVID-19 measures are still in place:

• Wearing a mask is mandatory in indoor public spaces
• Hand-washing stations are mandatory at state and private institutions

Is Port-au-Prince open for travel?

Port-au-Prince is open to all tourists now. Please make sure to abide by basic COVID-19 rules in order to experience the capital safely.

Do I have to go into quarantine if I go to Haiti?

As of April 2022, international travelers do not have to self-isolate upon arrival in Haiti if they do not have any symptoms of COVID-19.

How do I get a health pass to travel to Haiti?

At present, no health pass is required in Haiti.

Useful links:

• Haiti COVID-19 information

Visit our   Travel Restrictions section at Kiwi.com Stories   to read   more travel restrictions articles

COVID-19 travel hacks

Popular routes on Kiwi.com

• Cheap flights from Dubai to London
• Cheap flights from Vilnius to Tenerife
• Cheap flights from Nairobi to Eldoret
• Cheap flights from Tenerife to Vilnius
• Cheap flights from London to Prague
• Cheap flights from Barcelona to Tenerife
• Cheap flights from London to Athens
• Cheap flights from Cairo to Dubai
• Cheap flights from Berlin to Istanbul
• Cheap flights from Istanbul to Baku
• Cheap flights from London to Warsaw
• Cheap flights from London to Lisbon

3 simple ways to make traveling cost nothing (or very little)

We let you in on how to travel for free by utilizing travel hacks, getting alternative accommodation, and finding things to see and do on any vacation that don't cost a penny

World Travel Hackers: Get free travel accommodation

These are the sure-fire ways to get cheap, or even free accommodation when you travel! This, plus flight discounts and more from our World Travel Hackers

World Travel Hackers: How to avoid paying at the airport for oversized baggage

Don’t you just hate it when airlines charge you extra simply for bringing cabin baggage? Our World Travel Hackers share their tricks for avoiding these fees, and they take on more budget travel challenges

World Travel Hackers: Exploring Bohol, the Philippines on just €20

Can ChatGPT work as a travel guide? Plus, see how Kiwi.com’s newest travel hack works, and how to explore Medellín, Paris, and Bohol on a budget

Introducing Kiwi.com’s Price lock: freeze your flight price, pay later

Here’s another money-saving feature from Kiwi.com. But what is Price lock, how does it work, and how will it make travel cheaper for you?

10 ways to make economy class feel like first class

Anyone knows that first class is inherently incompatible with flying on a budget. But what if you could bring first class… to economy class? Here’s how, in 10 simple ways

Hack the system, fly for less

Guide to Affordable Phuket: How to Enjoy Thailand on the Cheap

Top Tips for Budget Travel — the World Travel Hackers’ Guide

Discovering Mexico City on a Budget: Culture, Cuisine, and More

A .gov website belongs to an official government organization in the United States.

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

• About Rabies
• Rabies Prevention and Control
• Rabies Status: Assessment by Country
• When to Seek Medical Care for Rabies
• Global Rabies: What You Should Know
• Clinical Overview of Rabies
• Information for Veterinarians
• Rabies pre- and post-exposure prophylaxis
• Rabies Symptoms and Specimen Collection
• Laboratory Information/Specimen Submission
• Protecting Public Health
• View All Home

Rabies Pre-exposure Prophylaxis

• Pre-exposure vaccination is recommended for persons who work directly with animals that could have rabies
• Also, those who travel to parts of the world where rabies is common and access to medical care is limited.

Pre-exposure vaccination (PrEV)

Most people in the United States have a low risk of encountering an animal with rabies. However, a small subset of people have a higher level of risk, like those who work directly with animals that could have rabies, or those who travel to parts of the world where rabies is common and access to medical care is limited. These people should receive rabies pre-exposure vaccination (PrEV), a series of rabies vaccine doses given before exposure to the rabies virus.

The Advisory Committee on Immunization Practices (ACIP) develops U.S. recommendations about how and when to use vaccines to prevent disease in the United States, including how to prevent rabies in people. ACIP updated rabies vaccine recommendations in May 2022, which are summarized below:

Updates to the ACIP recommendations to prevent human rabies, 2022

• A 2-dose PrEV schedule has replaced the 3-dose PrEV schedule to protect people from rabies for up to 3 years. Options for maintaining protection beyond 3 years are also described.
• Risk categories have been redefined into 5 risk groups.
• The minimum acceptable laboratory value (antibody titer) used to determine whether rabies vaccine booster doses are needed was revised and standardized.
• Many people for whom serial titers were recommended every 2 years now require only a one-time titer (and booster if below a certain level) OR a one-time booster.

Clinical guidance for administering PrEV to people with weakened immune systems has been outlined and includes recommendations to confirm that the vaccine was effective.

Risk category

Who this typically* affects

Recommendations

Risk category 1 Highest risk

People who work with live or concentrated rabies virus in laboratories

2 doses, days 0 and 7

• Check titer every 6 months

Risk category 2

People who frequently do at least one of the following: handle bats, have contact with bats, enter high-density bat environments like caves, or perform animal necropsies

• Check titer every 2 years

Risk category 3

People who interact with, or are at higher risk to interact, with mammals other than bats that could be rabid, for a period longer than three years after they receive PrEP.

This group includes:

• Most veterinarians, veterinary technicians, animal control officers, wildlife biologists, rehabilitators, trappers, and spelunkers (cave explorers)
• Certain travelers to regions outside of the United States where rabies in dogs is commonly found

2 doses, days 0 and 7, plus:

• Either a one-time titer check after 1 year and up to 3 years following the first 2-dose vaccination
• 1-dose booster between 3 weeks and 3 years following the first vaccine in the 2-dose vaccination

Risk category 4

Same population as risk category 3, but at a higher risk for ≤ three years after they receive PrEV

Risk category 5 Lowest risk

General U.S. population

* The typical characteristics described may not include the characteristics of all activities that fall within the described risk group.

For detailed information about these recommendations, please refer to the published MMWR .

Rabies is a preventable viral disease of mammals usually transmitted through the bite of an infected animal.

For Everyone

Health care providers, public health.

• COVID-19 travel advice

Considering travel during the pandemic? Take precautions to protect yourself from COVID-19.

A coronavirus disease 2019 (COVID-19) vaccine can prevent you from getting COVID-19 or from becoming seriously ill due to COVID-19 . But even if you're vaccinated, it's still a good idea to take precautions to protect yourself and others while traveling during the COVID-19 pandemic.

If you've had all recommended COVID-19 vaccine doses, including boosters, you're less likely to become seriously ill or spread COVID-19 . You can then travel more safely within the U.S. and internationally. But international travel can still increase your risk of getting new COVID-19 variants.

The Centers for Disease Control and Prevention (CDC) recommends that you should avoid travel until you've had all recommended COVID-19 vaccine and booster doses.

Before you travel

As you think about making travel plans, consider these questions:

• Have you been vaccinated against COVID-19 ? If you haven't, get vaccinated. If the vaccine requires two doses, wait two weeks after getting your second vaccine dose to travel. If the vaccine requires one dose, wait two weeks after getting the vaccine to travel. It takes time for your body to build protection after any vaccination.
• Have you had any booster doses? Having all recommended COVID-19 vaccine doses, including boosters, increases your protection from serious illness.
• Are you at increased risk for severe illness? Anyone can get COVID-19 . But older adults and people of any age with certain medical conditions are at increased risk for severe illness from COVID-19 .
• Do you live with someone who's at increased risk for severe illness? If you get infected while traveling, you can spread the COVID-19 virus to the people you live with when you return, even if you don't have symptoms.
• Does your home or destination have requirements or restrictions for travelers? Even if you've had all recommended vaccine doses, you must follow local, state and federal testing and travel rules.

Check local requirements, restrictions and situations

Some state, local and territorial governments have requirements, such as requiring people to wear masks, get tested, be vaccinated or stay isolated for a period of time after arrival. Before you go, check for requirements at your destination and anywhere you might stop along the way.

Keep in mind these can change often and quickly depending on local conditions. It's also important to understand that the COVID-19 situation, such as the level of spread and presence of variants, varies in each country. Check back for updates as your trip gets closer.

Travel and testing

For vaccinated people.

If you have been fully vaccinated, the CDC states that you don't need to get tested before or after your trip within the U.S. or stay home (quarantine) after you return.

If you're planning to travel internationally outside the U.S., the CDC states you don't need to get tested before your trip unless it's required at your destination. Before arriving to the U.S., you need a negative test within the last day before your arrival or a record of recovery from COVID-19 in the last three months.

After you arrive in the U.S., the CDC recommends getting tested with a viral test 3 to 5 days after your trip. If you're traveling to the U.S. and you aren't a citizen, you need to be fully vaccinated and have proof of vaccination.

You don't need to quarantine when you arrive in the U.S. But check for any symptoms. Stay at home if you develop symptoms.

For unvaccinated people

Testing before and after travel can lower the risk of spreading the virus that causes COVID-19 . If you haven't been vaccinated, the CDC recommends getting a viral test within three days before your trip. Delay travel if you're waiting for test results. Keep a copy of your results with you when you travel.

Repeat the test 3 to 5 days after your trip. Stay home for five days after travel.

If at any point you test positive for the virus that causes COVID-19 , stay home. Stay at home and away from others if you develop symptoms. Follow public health recommendations.

Stay safe when you travel

In the U.S., you must wear a face mask on planes, buses, trains and other forms of public transportation. The mask must fit snugly and cover both your mouth and nose.

Follow these steps to protect yourself and others when you travel:

• Get vaccinated.
• Keep distance between yourself and others (within about 6 feet, or 2 meters) when you're in indoor public spaces if you're not fully vaccinated. This is especially important if you have a higher risk of serious illness.
• Avoid contact with anyone who is sick or has symptoms.
• Avoid crowds and indoor places that have poor air flow (ventilation).
• Don't touch frequently touched surfaces, such as handrails, elevator buttons and kiosks. If you must touch these surfaces, use hand sanitizer or wash your hands afterward.
• Wear a face mask in indoor public spaces. The CDC recommends wearing the most protective mask possible that you'll wear regularly and that fits. If you are in an area with a high number of new COVID-19 cases, wear a mask in indoor public places and outdoors in crowded areas or when you're in close contact with people who aren't vaccinated.
• Avoid touching your eyes, nose and mouth.
• Cover coughs and sneezes.
• Wash your hands often with soap and water for at least 20 seconds.
• If soap and water aren't available, use a hand sanitizer that contains at least 60% alcohol. Cover all surfaces of your hands and rub your hands together until they feel dry.
• Don't eat or drink on public transportation. That way you can keep your mask on the whole time.

Because of the high air flow and air filter efficiency on airplanes, most viruses such as the COVID-19 virus don't spread easily on flights. Wearing masks on planes has likely helped lower the risk of getting the COVID-19 virus on flights too.

However, air travel involves spending time in security lines and airport terminals, which can bring you in close contact with other people. Getting vaccinated and wearing a mask when traveling can help protect you from COVID-19 while traveling.

The Transportation Security Administration (TSA) has increased cleaning and disinfecting of surfaces and equipment, including bins, at screening checkpoints. TSA has also made changes to the screening process:

• Travelers must wear masks during screening. However, TSA employees may ask travelers to adjust masks for identification purposes.
• Travelers should keep a distance of 6 feet apart from other travelers when possible.
• Instead of handing boarding passes to TSA officers, travelers should place passes (paper or electronic) directly on the scanner and then hold them up for inspection.
• Each traveler may have one container of hand sanitizer up to 12 ounces (about 350 milliliters) in a carry-on bag. These containers will need to be taken out for screening.
• Personal items such as keys, wallets and phones should be placed in carry-on bags instead of bins. This reduces the handling of these items during screening.
• Food items should be carried in a plastic bag and placed in a bin for screening. Separating food from carry-on bags lessens the likelihood that screeners will need to open bags for inspection.

Be sure to wash your hands with soap and water for at least 20 seconds directly before and after going through screening.

Public transportation

If you travel by bus or train and you aren't vaccinated, be aware that sitting or standing within 6 feet (2 meters) of others for a long period can put you at higher risk of getting or spreading COVID-19 . Follow the precautions described above for protecting yourself during travel.

Even if you fly, you may need transportation once you arrive at your destination. You can search car rental options and their cleaning policies on the internet. If you plan to stay at a hotel, check into shuttle service availability.

If you'll be using public transportation and you aren't vaccinated, continue physical distancing and wearing a mask after reaching your destination.

Hotels and other lodging

The hotel industry knows that travelers are concerned about COVID-19 and safety. Check any major hotel's website for information about how it's protecting guests and staff. Some best practices include:

• Enhanced cleaning procedures
• Physical distancing recommendations indoors for people who aren't vaccinated
• Mask-wearing and regular hand-washing by staff
• Mask-wearing indoors for guests in public places in areas that have high cases of COVID-19
• Vaccine recommendations for staff
• Isolation and testing guidelines for staff who've been exposed to COVID-19
• Contactless payment
• Set of rules in case a guest becomes ill, such as closing the room for cleaning and disinfecting
• Indoor air quality measures, such as regular system and air filter maintenance, and suggestions to add air cleaners that can filter viruses and bacteria from the air

Vacation rentals, too, are enhancing their cleaning procedures. They're committed to following public health guidelines, such as using masks and gloves when cleaning, and building in a waiting period between guests.

Make a packing list

When it's time to pack for your trip, grab any medications you may need on your trip and these essential safe-travel supplies:

• Alcohol-based hand sanitizer (at least 60% alcohol)
• Disinfectant wipes (at least 70% alcohol)
• Thermometer

Considerations for people at increased risk

Anyone can get very ill from the virus that causes COVID-19 . But older adults and people of any age with certain medical conditions are at increased risk for severe illness. This may include people with cancer, serious heart problems and a weakened immune system. Getting the recommended COVID-19 vaccine and booster doses can help lower your risk of being severely ill from COVID-19 .

Travel increases your chance of getting and spreading COVID-19 . If you're unvaccinated, staying home is the best way to protect yourself and others from COVID-19 . If you must travel and aren't vaccinated, talk with your health care provider and ask about any additional precautions you may need to take.

Remember safety first

Even the most detailed and organized plans may need to be set aside when someone gets ill. Stay home if you or any of your travel companions:

• Have signs or symptoms, are sick or think you have COVID-19
• Are waiting for results of a COVID-19 test
• Have been diagnosed with COVID-19
• Have had close contact with someone with COVID-19 in the past five days and you're not up to date with your COVID-19 vaccines

If you've had close contact with someone with COVID-19 , get tested after at least five days. Wait to travel until you have a negative test. Wear a mask if you travel up to 10 days after you've had close contact with someone with COVID-19 .

• How to protect yourself and others. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html. Accessed Feb. 4, 2022.
• Domestic travel during COVID-19. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/travelers/travel-during-covid19.html. Accessed Feb. 4, 2022.
• Requirement for face masks on public transportation conveyances and at transportation hubs. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/travelers/face-masks-public-transportation.html. Accessed Feb. 4, 2022.
• International travel. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/travelers/international-travel/index.html. Accessed Feb. 4, 2022.
• U.S citizens, U.S. nationals, U.S. lawful permanent residents, and immigrants: Travel to and from the United States. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/travelers/international-travel-during-covid19.html. Accessed Feb. 4, 2022.
• Non-US. citizen, non-U.S. immigrants: Air travel to the United States. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/travelers/noncitizens-US-air-travel.html. Accessed Feb. 4, 2022.
• People with certain medical conditions. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html. Accessed Feb. 4, 2022.
• Stay up to date with your vaccines. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html. Accessed Feb. 4, 2022.
• Pack smart. Centers for Disease Control and Prevention. https://wwwnc.cdc.gov/travel/page/pack-smart. Accessed Feb. 4, 2022.
• Travel: Frequently asked questions. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/travelers/faqs.html. Accessed Feb. 7, 2022.
• Coronavirus (COVID-19) information. Transportation Security Administration. https://www.tsa.gov/coronavirus. Accessed Feb. 7, 2022.
• WHO advice for international traffic in relation to the SARS-CoV-2 Omicron variant (B.1.1.529). World Health Organization. https://www.who.int/news-room/articles-detail/who-advice-for-international-traffic-in-relation-to-the-sars-cov-2-omicron-variant. Accessed Feb. 7, 2022.
• VRHP/VRMA Cleaning guidelines for COVID-19. Vacation Rental Management Association. https://www.vrma.org/page/vrhp/vrma-cleaning-guidelines-for-covid-19. Accessed Feb. 7, 2022.
• Safe stay. American Hotel & Lodging Association. https://www.ahla.com/safestay. Accessed Feb. 7, 2022.
• Khatib AN, et al. COVID-19 transmission and the safety of air travel during the pandemic: A scoping review. Current Opinion in Infectious Diseases. 2021; doi:10.1097/QCO.0000000000000771.

Products and Services

• A Book: Endemic - A Post-Pandemic Playbook
• Begin Exploring Women's Health Solutions at Mayo Clinic Store
• A Book: Future Care
• Antibiotics: Are you misusing them?
• COVID-19 and vitamin D
• Convalescent plasma therapy
• Coronavirus disease 2019 (COVID-19)
• COVID-19: How can I protect myself?
• Herd immunity and respiratory illness
• COVID-19 and pets
• COVID-19 and your mental health
• COVID-19 antibody testing
• COVID-19, cold, allergies and the flu
• Long-term effects of COVID-19
• COVID-19 tests
• COVID-19 drugs: Are there any that work?
• COVID-19 in babies and children
• Coronavirus infection by race
• COVID-19 vaccine: Should I reschedule my mammogram?
• COVID-19 vaccines for kids: What you need to know
• COVID-19 vaccines
• COVID-19 variant
• COVID-19 vs. flu: Similarities and differences
• COVID-19: Who's at higher risk of serious symptoms?
• Debunking coronavirus myths
• Different COVID-19 vaccines
• Extracorporeal membrane oxygenation (ECMO)
• Fever: First aid
• Fever treatment: Quick guide to treating a fever
• Fight coronavirus (COVID-19) transmission at home
• Honey: An effective cough remedy?
• How do COVID-19 antibody tests differ from diagnostic tests?
• How to measure your respiratory rate
• How to take your pulse
• How to take your temperature
• How well do face masks protect against COVID-19?
• Is hydroxychloroquine a treatment for COVID-19?
• Loss of smell
• Mayo Clinic Minute: You're washing your hands all wrong
• Mayo Clinic Minute: How dirty are common surfaces?
• Multisystem inflammatory syndrome in children (MIS-C)
• Nausea and vomiting
• Pregnancy and COVID-19
• Safe outdoor activities during the COVID-19 pandemic
• Safety tips for attending school during COVID-19
• Sex and COVID-19
• Shortness of breath
• Thermometers: Understand the options
• Treating COVID-19 at home
• Unusual symptoms of coronavirus
• Vaccine guidance from Mayo Clinic
• Watery eyes

Related Information

• Coronavirus: What is it and how can I protect myself?
• COVID-19 vaccines: Get the facts
• COVID-19 , cold, allergies and the flu: What are the differences?

Your gift holds great power – donate today!

Make your tax-deductible gift and be part of the cutting-edge research and care that's changing medicine.

Archived CDC Vaccine Price List as of April 1, 2024

Pediatric/vfc vaccine price list, adult vaccine price list, pediatric influenza vaccine price list, adult influenza vaccine price list, pediatric covid-19 vaccine price list, adult covid-19 vaccine price list.

« Back to Vaccines For Children program « Back to Immunization Managers Home page

Prices last reviewed/updated: April 1, 2024

Note 1: The CDC Vaccine Price Lists posted on this website provide current vaccine contract prices and list the private sector vaccine prices for general information. Contract prices are those for CDC vaccine contracts that are established for the purchase of vaccines by immunization programs that receive CDC immunization cooperative agreement funds (i.e., state health departments, certain large city immunization projects, and certain current and former U.S. territories). Private providers and private citizens cannot directly purchase vaccines through CDC contracts. Private sector prices are those reported by vaccine manufacturers annually to CDC. All questions regarding the private sector prices should be directed to the manufacturers.

Note 2: The CDC price list does not represent all possible routinely recommended vaccine presentations available to providers in the United States. The price list represents only those vaccine presentations available through CDC contracts.

• Vaccine Supply Information (for routine vaccines)
• Vaccine package insert information From this page, you can get to all of the vaccines licensed in the US. Each product page includes links to the prescribing information (package inserts).

As of 5-14-10, the CDC Vaccine Price List also shows the NDC code and contract number for each vaccine.

Archived Pages:

• Current Price List
• Archived Prices list 2001-present

Note: The table below reflects contracts for the 2024-2025 Pediatric Flu.

Note: The table below reflects contracts for the 2024-2025 Adult Flu.

Note: The table below reflects contracts for the 2023-2024 Pediatric COVID-19.

Note: The table below reflects contracts for the 2023-2024 Adult COVID-19.

• CDC Vaccine cost includes $2.25 per dose Federal Excise Tax
• CDC Vaccine cost includes $3.00 per dose Federal Excise Tax
• CDC Vaccine cost includes $1.50 per dose Federal Excise Tax
• CDC Vaccine cost includes $3.75 per dose Federal Excise Tax
• CDC Vaccine cost includes $0.75 per dose Federal Excise Tax
• CDC Vaccine cost includes $4.50 per dose Federal Excise Tax

CDC updates recommendation for RSV vaccination

(WIFR) - The Centers for Disease Control clarifies its recommendation about adults who should get an Respiratory Syncytial Virus or RSV vaccine.

For the upcoming virus season, the CDC recommends the following groups of people receive the RSV vaccine:

• Everyone ages 75 and older
• People ages 60-74 who are at an increased risk of severe RSV, meaning they have certain chronic medical conditions, such as lung or heart disease, or who live in nursing homes

The updated recommendation is based on new data and is designed to make decision-making about the RSV vaccine easier for health care workers and the public.

The immunization is is not an annual vaccine, meaning people do not need to get it every RSV season. The vaccines were available last year to protect people at increased risk for severe RSV, including infants and young children.

The CDC says healthcare providers should recommend RSV vaccines to their eligible patients and discuss what other vaccines they will need this fall to help prevent respiratory infections.

For more information about RSV, visit the CDC’s website .

Copyright 2024 WIFR. All rights reserved.

Rockford firefighters battle garage fire, rescue residents

Pattern to turn stormy beginning Tuesday

Chicago man charged in 2021 Rockford murder

Davis man charged in neighbor dispute near Durand

Multiple northern Illinois areas added to lead poisoning high-risk list

Rockford police identify, search for UW Health Swedish American Hospital burgarly suspect

FIRST ALERT: Scattered showers & t-storms this morning, strong/severe storms possible tonight

Red Barn Golf Course reportedly suggests homeowners pay for its $187,000 driving range net

Latest news.

Fire forces demolition of Rockford home

Red Barn Golf Course reportedly suggests homeowners pay for its driving range net

Annamarie sits down with Joe Mantello and Laurie Metcalf

Rockford native directs world premiere of Chicago play

CDC recommends updated COVID-19 vaccination for this fall

(CNN) – The Centers for Disease Control and Prevention announced this week anyone six months of age and older should receive one of the new COVID-19 vaccines when they become available this fall.

Updated vaccines give targeted protection from a virus, and immunity from a previous shot or infection decreases over time.

This new CDC recommendation comes as the United States faces a rise in cases of COVID-19 across most states.

The CDC says most people who got the last COVID-19 vaccine had increased protection against hospital visits compared with people who had no shot.

The Affordable Care Act requires insurers, including Medicare and Medicaid, to pay for vaccines recommended by the advisory committee at no cost to the patient.

Copyright 2024 CNN Newsource. All rights reserved.

NEW INFORMATION: Tucson Police investigating apparent murder-suicide

NEW DETAILS: Man identified following standoff at Tucson apartment complex

Woman killed in two-vehicle crash with suspected DUI driver

NEW INFORMATION: 200 children found in nationwide operation that included Tucson

Police: Tucson man shook random child at Dairy Queen

NEW DETAILS: One dead, another facing charges following Tucson shooting

Missing Pima County Sheriff’s Department K-9 Daemen found safe

Power company says everyone should follow ‘20-degree’ rule when setting thermostat on hot days

Latest news.

Here are the best and worst states and districts for USPS mail delivery

Fireworks caused 9,700 injuries last year during 4th of July celebrations, study says

Neurologist reacts to new Alzheimer's drug

To save spotted owls, US officials plan to kill hundreds of thousands of another owl species

Unhoused in Pima County will not be punished following Supreme Court ruling

Vaquero is our Unscripted on 13+ Pet of the Week

Hurricane Beryl roars toward Jamaica after killing at least 6 people in the southeast Caribbean